SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 17 of 100
Health
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By
Angel Adegbesan
and
Bloomberg
October 13, 2023
Health
Horseshoe crab blood is vital to modern medicine. A new lab-made alternative could save the species
By
Kristoffer Whitney
,
Jolie Crunelle
and
The Conversation
October 13, 2023
Health
CVS CEO says pharmacist burnout led to a walkout: ‘We are at the same level of demand as we were in 2021’ for COVID shots
By
Erin Prater
October 10, 2023
Finance
Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By
Prarthana Prakash
October 10, 2023
Health
‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By
Tom Murphy
and
The Associated Press
October 7, 2023
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Chloe Taylor
October 5, 2023
Finance
Drugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By
Prarthana Prakash
October 4, 2023
Health
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By
Erin Prater
October 2, 2023
Success
CVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
By
Josh Funk
and
The Associated Press
September 28, 2023
Commentary
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
By
Howard Dean
September 19, 2023
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By
Prarthana Prakash
September 5, 2023
Commentary
Smoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By
Jeffrey Sonnenfeld
August 31, 2023
Commentary
U.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By
John G. Singer
August 10, 2023
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By
Erin Prater
August 8, 2023
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By
Vivienne Walt
July 31, 2023
Most Popular
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
AI
Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
By
Nick Lichtenberg
Success
Blackstone exec says elite Ivy League degrees aren’t good enough—new analysts need to ‘work harder’ and be nice
By
Ashley Lutz